April 13, 2018
Rose
It's the first screening device the FDA has authorized that doesn't need a clinician's interpretation to look for a particular condition. In other news, the agency also is going to relax its review of next-generation sequencing tests.
from Kaiser Health News https://ift.tt/2vb5cKf
April 13, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
KHN’s ‘What the Health?’: A Conversation With Peter Lee on What’s Next for the ACA- Judge’s Ruling on the CDC Mask Mandate Highlights the Limits of the Agency’s Power
- Clínica de abortos en la frontera de Texas enfrenta desafíos legales y culturales únicos
- Is My Drug Copay Coupon a Form of Charity — Or a Bribe?
- Anti-Vaccine Ideology Gains Ground as Lawmakers Seek to Erode Rules for Kids’ Shots
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment